Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Assets Average (2023 - 2025)

Historic Assets Average for Indivior Pharmaceuticals (INDV) over the last 3 years, with Q3 2025 value amounting to $1.4 billion.

  • Indivior Pharmaceuticals' Assets Average fell 436.81% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 436.81%. This contributed to the annual value of $1.5 billion for FY2024, which is 1284.38% down from last year.
  • Latest data reveals that Indivior Pharmaceuticals reported Assets Average of $1.4 billion as of Q3 2025, which was down 436.81% from $1.4 billion recorded in Q2 2025.
  • Indivior Pharmaceuticals' Assets Average's 5-year high stood at $1.8 billion during Q4 2023, with a 5-year trough of $1.3 billion in Q1 2025.
  • Its 3-year average for Assets Average is $1.6 billion, with a median of $1.5 billion in 2024.
  • Per our database at Business Quant, Indivior Pharmaceuticals' Assets Average crashed by 2299.17% in 2024 and then plummeted by 436.81% in 2025.
  • Over the past 3 years, Indivior Pharmaceuticals' Assets Average (Quarter) stood at $1.8 billion in 2023, then fell by 22.99% to $1.4 billion in 2024, then grew by 3.17% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q3 2025, $1.4 billion for Q2 2025, and $1.3 billion during Q1 2025.